Table 1.
Study population characteristics comparing screening and diagnostic PSA test groups
| Total count | Screening (n = 1884) | Diagnostic (n = 1150) | |
|---|---|---|---|
| Variables | N (col %) | N (col %) | |
| Number of patients | |||
| 3034 | 1884 (62.1) | 1150 (37.9) | |
| Age at diagnosis (in years) | |||
| 68–74 | 1923 | 1259 (66.8) | 664 (57.7) |
| 75–84 | 945 | 571 (30.3) | 374 (32.5) |
| ≥ 85 | 166 | 54 (2.9) | 112 (9.7) |
| Race | |||
| White | 2686 | 1668 (88.5) | 1018 (88.5) |
| Non-white | 348 | 216 (11.5) | 132 (11.5) |
| Marital status | |||
| Married | 2174 | 1378 (73.1) | 796 (69.2) |
| Separated/divorced | 194 | 119 (6.3) | 75 (6.5) |
| Widowed | 265 | 153 (8.1) | 112 (9.7) |
| Single | 237 | 144 (7.6) | 93 (8.1) |
| Unknown | 164 | 90 (4.8) | 74 (6.4) |
| Geographic area | |||
| Metropolitan | 2005 | 1239 (65.8) | 766 (66.6) |
| Appalachian | 524 | 335 (17.8) | 189 (16.4) |
| Rural | 505 | 310 (16.5) | 195 (17.0) |
| Area poverty level | |||
| < 5% | 899 | 538 (28.6) | 361 (31.4) |
| 5.00–9.99% | 812 | 518 (27.5) | 294 (25.6) |
| 10.00–19.99% | 836 | 539 (28.6) | 297 (25.8) |
| ≥ 20% | 487 | 289 (15.3) | 198 (17.2) |
| Claims-based frailty index | |||
| Non-frail (score < 0.1) | 630 | 446 (23.7) | 184 (16.0) |
| Pre-frail (0.1–0.19) | 2189 | 1328 (70.5) | 861 (74.9) |
| Mildly-severely frail (score ≥ 0.20) | 215 | 110 (5.8) | 105 (9.1) |
| Stage of prostate cancer diagnosis | |||
| Localized | 2358 | 1512 (80.3) | 846 (73.6) |
| Regional | 390 | 251 (13.3) | 139 (12.1) |
| Distant | 286 | 121 (6.4) | 165 (14.3) |